Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Urol Oncol. 2022 Nov 15;41(2):106.e17–106.e23. doi: 10.1016/j.urolonc.2022.10.002

Figure 3:

Figure 3:

Hazard ratios of chr8q bands for metastasis (MET) and prostate cancer specific mortality (PCSM) in localized natural history cohort without (red) and with adjusting for high Decipher. Most chr8q bands are associated with poor outcome and remained significant after adjusting for high Decipher.